TLR9 and metabolic dysfunction-associated steatohepatitis: Elevated levels of circulating mtDNA in patients with NASH and NASH-associated fibrosis, along with the association between TLR9 pathway activation and NASH disease severity, is strongly suggestive when combined with the mechanistic animal models of disease.